Stay updated on Clinical Trial: Fycompa in Adolescence Epilepsy Patients

Sign up to get notified when there's something new on the Clinical Trial: Fycompa in Adolescence Epilepsy Patients page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Fycompa in Adolescence Epilepsy Patients page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T22:45:16.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the investigation of the clinical safety and efficacy of long-term treatment with Fycompa tablets in adolescent epilepsy patients with partial-onset seizures or primary generalized tonic-clonic seizures.
    Difference
    0.2%
    Check dated 2024-06-06T14:42:54.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that epilepsy patients aged 12 to 17 with partial seizures or primary generalized tonic-clonic seizures are eligible. Previously, no information was provided regarding participation criteria.
    Difference
    11%
    Check dated 2024-05-22T21:18:36.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:39:30.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Fycompa in Adolescence Epilepsy Patients

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Fycompa in Adolescence Epilepsy Patients page.